BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19438479)

  • 1. Advances in understanding the bleeding diathesis in factor V deficiency.
    Duckers C; Simioni P; Rosing J; Castoldi E
    Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parahemophilia: new insights into factor v deficiency.
    Thalji N; Camire RM
    Semin Thromb Hemost; 2013 Sep; 39(6):607-12. PubMed ID: 23893775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression.
    Yang TL; Cui J; Taylor JM; Yang A; Gruber SB; Ginsburg D
    Thromb Haemost; 2000 Jan; 83(1):70-7. PubMed ID: 10669158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP; Majerus DW; Majerus PW
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
    Duckers C; Simioni P; Spiezia L; Radu C; Dabrilli P; Gavasso S; Rosing J; Castoldi E
    Blood; 2010 Jan; 115(4):879-86. PubMed ID: 19861681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
    Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
    J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage requirements of factor V in tissue-factor induced thrombin generation.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Thromb Haemost; 1998 Jul; 80(1):92-8. PubMed ID: 9684792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V deficiency.
    Asselta R; Peyvandi F
    Semin Thromb Hemost; 2009 Jun; 35(4):382-9. PubMed ID: 19598066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency.
    Delev D; Pavlova A; Heinz S; Seifried E; Oldenburg J
    Haemophilia; 2009 Sep; 15(5):1143-53. PubMed ID: 19486170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.
    Duckers C; Simioni P; Spiezia L; Radu C; Gavasso S; Rosing J; Castoldi E
    Blood; 2008 Nov; 112(9):3615-23. PubMed ID: 18695002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.
    Cui J; O'Shea KS; Purkayastha A; Saunders TL; Ginsburg D
    Nature; 1996 Nov; 384(6604):66-8. PubMed ID: 8900278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a novel mutation of human blood coagulation FV gene associated with congenital FV deficiency].
    Fu WJ; Hou J; Wang DX; Yu RQ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):119-21. PubMed ID: 12697120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V.
    Spiezia L; Radu C; Campello E; Bulato C; Bertini D; Barillari G; De Angelis V; Pradella P; Zanon E; Simioni P
    Haemophilia; 2012 May; 18(3):463-8. PubMed ID: 22176523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V deficiency: a concise review.
    Huang JN; Koerper MA
    Haemophilia; 2008 Nov; 14(6):1164-9. PubMed ID: 19141156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential.
    Perrin J; Lecompte T; Tournier A; Morlon L; Marchand-Arvier M; Vigneron C
    Thromb Haemost; 2010 Sep; 104(3):514-22. PubMed ID: 20589323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population.
    Castoldi E; Lunghi B; Mingozzi F; Muleo G; Redaelli R; Mariani G; Bernardi F
    Haematologica; 2001 Jun; 86(6):629-33. PubMed ID: 11418372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel mutation causes congenital factor V deficiency].
    Hou LH; Xie F; Liu XE; Zhang L; Guo YL; Dong CX; Li ZT; Yang B; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):455-9. PubMed ID: 14575586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.
    Shao Y; Wu W; Xu G; Wang X; Ding Q
    Blood; 2019 Nov; 134(20):1745-1754. PubMed ID: 31558466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.